Guangzhou Kingmed Diagnostics Group Co., Ltd.
603882Biotechnology
CN¥28.59−9.55%As of Oct 29vs prior close
- Market cap
- $2B
- P/E (TTM)
- 142.9×
- P/E (FY1)
- 23.9×
- From 52W high
- −20.62%
- EPS (LTM)
- CN¥0.22
- Revenue (LTM)
- CN¥5.9B
- Net margin
- 4.75%
- Dividend yield
- 3.08%
Nomior Score
45
Steady ProfileBottom 40% of the scored universe
Growth41
Quality57
Value52
Momentum44
Resilience47
Growth
−26.96%revenue a year over 3 fiscal years
YE22 CN¥15.5BLTM CN¥5.9B
Connections
Revenue to profitYE25
The net loss was 3% of revenue, narrower by 2 pts on a year.